JPWO2016125208A1 - アナツバメ巣を原材料とする素材、組成物及び素材の製造方法 - Google Patents
アナツバメ巣を原材料とする素材、組成物及び素材の製造方法 Download PDFInfo
- Publication number
- JPWO2016125208A1 JPWO2016125208A1 JP2016572943A JP2016572943A JPWO2016125208A1 JP WO2016125208 A1 JPWO2016125208 A1 JP WO2016125208A1 JP 2016572943 A JP2016572943 A JP 2016572943A JP 2016572943 A JP2016572943 A JP 2016572943A JP WO2016125208 A1 JPWO2016125208 A1 JP WO2016125208A1
- Authority
- JP
- Japan
- Prior art keywords
- raw material
- yeast
- nest
- swallow
- genus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002994 raw material Substances 0.000 title claims abstract description 47
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 11
- 239000002131 composite material Substances 0.000 title 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 42
- 239000000203 mixture Substances 0.000 claims abstract description 32
- 239000000463 material Substances 0.000 claims abstract description 28
- 235000015872 dietary supplement Nutrition 0.000 claims abstract description 20
- 239000003814 drug Substances 0.000 claims abstract description 20
- 239000000047 product Substances 0.000 claims abstract description 20
- 235000005770 birds nest Nutrition 0.000 claims abstract description 12
- 229940079593 drug Drugs 0.000 claims abstract description 12
- 235000005765 wild carrot Nutrition 0.000 claims abstract description 12
- 244000000626 Daucus carota Species 0.000 claims abstract description 11
- 235000021067 refined food Nutrition 0.000 claims abstract description 11
- 235000014214 soft drink Nutrition 0.000 claims abstract description 9
- 238000000855 fermentation Methods 0.000 claims description 31
- 230000004151 fermentation Effects 0.000 claims description 31
- 208000004296 neuralgia Diseases 0.000 claims description 11
- 208000021722 neuropathic pain Diseases 0.000 claims description 11
- 208000023589 ischemic disease Diseases 0.000 claims description 8
- 208000004454 Hyperalgesia Diseases 0.000 claims description 7
- 206010053552 allodynia Diseases 0.000 claims description 7
- 230000006872 improvement Effects 0.000 claims description 7
- 201000010099 disease Diseases 0.000 claims description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 6
- 230000009385 viral infection Effects 0.000 claims description 5
- 206010020772 Hypertension Diseases 0.000 claims description 4
- 230000000747 cardiac effect Effects 0.000 claims description 4
- 230000002490 cerebral effect Effects 0.000 claims description 4
- 206010012601 diabetes mellitus Diseases 0.000 claims description 4
- 230000002265 prevention Effects 0.000 claims description 4
- 238000001704 evaporation Methods 0.000 claims description 3
- 235000013305 food Nutrition 0.000 abstract description 17
- 238000000034 method Methods 0.000 abstract description 7
- 229930014626 natural product Natural products 0.000 abstract description 7
- 235000016709 nutrition Nutrition 0.000 abstract description 2
- 230000035764 nutrition Effects 0.000 abstract description 2
- 239000013589 supplement Substances 0.000 abstract description 2
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 31
- 239000007788 liquid Substances 0.000 description 16
- 239000003795 chemical substances by application Substances 0.000 description 14
- SQVRNKJHWKZAKO-UHFFFAOYSA-N beta-N-Acetyl-D-neuraminic acid Natural products CC(=O)NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO SQVRNKJHWKZAKO-UHFFFAOYSA-N 0.000 description 12
- SQVRNKJHWKZAKO-PFQGKNLYSA-N N-acetyl-beta-neuraminic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)O[C@H]1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-PFQGKNLYSA-N 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 208000024891 symptom Diseases 0.000 description 7
- 239000000243 solution Substances 0.000 description 6
- 241000235070 Saccharomyces Species 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 208000036142 Viral infection Diseases 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 230000003574 anti-allodynic effect Effects 0.000 description 4
- 239000012141 concentrate Substances 0.000 description 4
- 239000003755 preservative agent Substances 0.000 description 4
- 230000028327 secretion Effects 0.000 description 4
- 102000004127 Cytokines Human genes 0.000 description 3
- 108090000695 Cytokines Proteins 0.000 description 3
- -1 buccals Substances 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 238000000354 decomposition reaction Methods 0.000 description 3
- 239000003797 essential amino acid Substances 0.000 description 3
- 235000020776 essential amino acid Nutrition 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- SQVRNKJHWKZAKO-OQPLDHBCSA-N sialic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)OC1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-OQPLDHBCSA-N 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 239000003381 stabilizer Substances 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 241000208140 Acer Species 0.000 description 2
- 241000429775 Acraea rogersi Species 0.000 description 2
- 241000203244 Aerodramus brevirostris Species 0.000 description 2
- 241000352200 Aerodramus hirundinaceus Species 0.000 description 2
- 241000203250 Aerodramus salangana Species 0.000 description 2
- 241000203248 Aerodramus sawtelli Species 0.000 description 2
- 241000999994 Aerodramus vanikorensis Species 0.000 description 2
- 241001225657 Aerodramus vulcanorum Species 0.000 description 2
- 241000999993 Aerodramus whiteheadi Species 0.000 description 2
- 241000746665 Amorphophallus palawanensis Species 0.000 description 2
- 241000062811 Apus unicolor Species 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- 206010013786 Dry skin Diseases 0.000 description 2
- 102000018233 Fibroblast Growth Factor Human genes 0.000 description 2
- 108050007372 Fibroblast Growth Factor Proteins 0.000 description 2
- 241000167880 Hirundinidae Species 0.000 description 2
- 241000358884 Ischnosiphon leucophaeus Species 0.000 description 2
- 208000002720 Malnutrition Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 241000009148 Phyllangia papuensis Species 0.000 description 2
- 241000235645 Pichia kudriavzevii Species 0.000 description 2
- 240000003294 Thysanolaena latifolia Species 0.000 description 2
- 230000004099 anaerobic respiration Effects 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 230000037336 dry skin Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 229940126864 fibroblast growth factor Drugs 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000013355 food flavoring agent Nutrition 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 239000007937 lozenge Substances 0.000 description 2
- 230000001071 malnutrition Effects 0.000 description 2
- 235000000824 malnutrition Nutrition 0.000 description 2
- 206010027175 memory impairment Diseases 0.000 description 2
- 244000000010 microbial pathogen Species 0.000 description 2
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 2
- 208000015380 nutritional deficiency disease Diseases 0.000 description 2
- 239000003002 pH adjusting agent Substances 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 210000003079 salivary gland Anatomy 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000375 suspending agent Substances 0.000 description 2
- 239000011345 viscous material Substances 0.000 description 2
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
- 241000235646 Cyberlindnera jadinii Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000178951 Endomyces Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 239000004606 Fillers/Extenders Substances 0.000 description 1
- 244000286779 Hansenula anomala Species 0.000 description 1
- 235000014683 Hansenula anomala Nutrition 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 102000004889 Interleukin-6 Human genes 0.000 description 1
- 108090001005 Interleukin-6 Proteins 0.000 description 1
- 241001159781 Kazachstania spencerorum Species 0.000 description 1
- 241000039979 Kazachstania turicensis Species 0.000 description 1
- 241001123232 Kazachstania unispora Species 0.000 description 1
- 241000965982 Kazachstania zonata Species 0.000 description 1
- 241000235649 Kluyveromyces Species 0.000 description 1
- 244000285963 Kluyveromyces fragilis Species 0.000 description 1
- 235000014663 Kluyveromyces fragilis Nutrition 0.000 description 1
- 241000235087 Lachancea kluyveri Species 0.000 description 1
- 241000937897 Meyerozyma caribbica Species 0.000 description 1
- 241001123224 Naumovozyma dairenensis Species 0.000 description 1
- 229940123973 Oxygen scavenger Drugs 0.000 description 1
- 241000235648 Pichia Species 0.000 description 1
- 241000235072 Saccharomyces bayanus Species 0.000 description 1
- 241000198071 Saccharomyces cariocanus Species 0.000 description 1
- 241000877399 Saccharomyces chevalieri Species 0.000 description 1
- 235000018370 Saccharomyces delbrueckii Nutrition 0.000 description 1
- 241000877401 Saccharomyces ellipsoideus Species 0.000 description 1
- 241001407717 Saccharomyces norbensis Species 0.000 description 1
- 241001123227 Saccharomyces pastorianus Species 0.000 description 1
- 241000582914 Saccharomyces uvarum Species 0.000 description 1
- 241000235003 Saccharomycopsis Species 0.000 description 1
- 241000235346 Schizosaccharomyces Species 0.000 description 1
- 241000235347 Schizosaccharomyces pombe Species 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 239000004288 Sodium dehydroacetate Substances 0.000 description 1
- 239000004283 Sodium sorbate Substances 0.000 description 1
- 241001278026 Starmerella bombicola Species 0.000 description 1
- 241000235006 Torulaspora Species 0.000 description 1
- 244000288561 Torulaspora delbrueckii Species 0.000 description 1
- 235000014681 Torulaspora delbrueckii Nutrition 0.000 description 1
- 241000684582 Torulaspora microellipsoides Species 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 241000235017 Zygosaccharomyces Species 0.000 description 1
- 241000235033 Zygosaccharomyces rouxii Species 0.000 description 1
- 241000192248 [Candida] saitoana Species 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000002216 antistatic agent Substances 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 239000006172 buffering agent Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000004088 foaming agent Substances 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 239000012729 immediate-release (IR) formulation Substances 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 229940100601 interleukin-6 Drugs 0.000 description 1
- 238000006317 isomerization reaction Methods 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 239000004611 light stabiliser Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 229940126601 medicinal product Drugs 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000008177 pharmaceutical agent Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 235000010241 potassium sorbate Nutrition 0.000 description 1
- 239000004302 potassium sorbate Substances 0.000 description 1
- 229940069338 potassium sorbate Drugs 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 229960002181 saccharomyces boulardii Drugs 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 125000005629 sialic acid group Chemical group 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000019259 sodium dehydroacetate Nutrition 0.000 description 1
- 229940079839 sodium dehydroacetate Drugs 0.000 description 1
- LROWVYNUWKVTCU-STWYSWDKSA-M sodium sorbate Chemical compound [Na+].C\C=C\C=C\C([O-])=O LROWVYNUWKVTCU-STWYSWDKSA-M 0.000 description 1
- 235000019250 sodium sorbate Nutrition 0.000 description 1
- DSOWAKKSGYUMTF-GZOLSCHFSA-M sodium;(1e)-1-(6-methyl-2,4-dioxopyran-3-ylidene)ethanolate Chemical compound [Na+].C\C([O-])=C1/C(=O)OC(C)=CC1=O DSOWAKKSGYUMTF-GZOLSCHFSA-M 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 1
- 239000004034 viscosity adjusting agent Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 230000037373 wrinkle formation Effects 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/064—Saccharomycetales, e.g. baker's yeast
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Non-Alcoholic Beverages (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (11)
- アマツバメ科アナツバメ属に属する鳥の巣の酵母発酵物。
- 医薬品、医薬部外品、健康補助用食品、栄養補助用食品、加工食品及び清涼飲料水のいずれかとしての使用のための、
請求項1に記載の酵母発酵物。 - アマツバメ科アナツバメ属に属する鳥の巣の酵母発酵物を含有する組成物。
- 医薬品、医薬部外品、健康補助用食品、栄養補助用食品、加工食品及び清涼飲料水のいずれかである、
請求項3に記載の組成物。 - アロディニア又は神経因性疼痛を改善するための、
請求項3に記載の組成物。 - 生活習慣病の予防及び改善のうち少なくとも一方のための、
請求項3に記載の組成物。 - 前記生活習慣病は糖尿病、高血圧症、心虚血疾患及び脳虚血疾患のうちの少なくともいずれか一つである、
請求項6に記載の組成物。 - ウイルス感染を防ぐための、
請求項3に記載の組成物。 - アマツバメ科アナツバメ属に属する鳥の巣を原料とし、
前記原料に酵母を添加し、
前記原料を前記酵母で発酵させる、
素材製造方法。 - 発酵前の前記原料にさらに水分を添加し、
前記原料を前記水分とともに発酵させ、
発酵は密閉状態で行う、
請求項9に記載の素材製造方法。 - 発酵後、前記水分の少なくとも一部を蒸発させる、
請求項10に記載の素材製造方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2015031065 | 2015-02-03 | ||
JP2015031065 | 2015-02-03 | ||
PCT/JP2015/003205 WO2016125208A1 (ja) | 2015-02-03 | 2015-06-25 | アナツバメ巣を原材料とする素材、組成物及び素材の製造方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPWO2016125208A1 true JPWO2016125208A1 (ja) | 2017-11-16 |
JP6651466B2 JP6651466B2 (ja) | 2020-02-19 |
Family
ID=56563575
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2016572943A Active JP6651466B2 (ja) | 2015-02-03 | 2015-06-25 | アナツバメ巣を原材料とする酵母発酵液、組成物及び素材の製造方法 |
Country Status (4)
Country | Link |
---|---|
JP (1) | JP6651466B2 (ja) |
CN (1) | CN107405365B (ja) |
SG (1) | SG11201705801VA (ja) |
WO (1) | WO2016125208A1 (ja) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112931862A (zh) * | 2021-03-15 | 2021-06-11 | 北京市小仙炖电子商务有限公司 | 一种冰糖燕窝及其制备方法 |
Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0242962A (ja) * | 1988-08-04 | 1990-02-13 | Susumu Murofushi | 機能性食品の製造方法 |
JPH05214003A (ja) * | 1992-02-04 | 1993-08-24 | Mect Corp | 好中球遊走阻止薬 |
JP2002068988A (ja) * | 2000-08-23 | 2002-03-08 | Combi Corp | ウイルス感染抑制剤及びそれを含有する飲食品 |
JP2003259835A (ja) * | 2001-12-28 | 2003-09-16 | Oubiken:Kk | 発酵製品の製造とその利用 |
JP2003292444A (ja) * | 2002-02-04 | 2003-10-15 | Kyowa Hakko Kogyo Co Ltd | インスリン分泌促進剤 |
JP2005185242A (ja) * | 2003-12-26 | 2005-07-14 | Takashi Kondo | プラセンタを含有した健康食品及びその製造方法 |
JP2005185241A (ja) * | 2003-12-26 | 2005-07-14 | Takashi Kondo | 発酵健康食品及びその製造方法 |
JP2007061058A (ja) * | 2005-09-02 | 2007-03-15 | Hideo Yamamoto | 糖鎖栄養素を含む免疫強化食品及びその製造方法 |
JP2008189635A (ja) * | 2007-02-08 | 2008-08-21 | Nippon Zoki Pharmaceut Co Ltd | 疼痛疾患治療剤 |
WO2009008362A1 (ja) * | 2007-07-12 | 2009-01-15 | Yotsuba Milk Products Co., Ltd. | シアル酸化合物含有組成物の製造方法 |
JP2014159491A (ja) * | 2014-06-09 | 2014-09-04 | Combi Corp | コラーゲン産生低下抑制剤、それを含む皮膚外用組成物および化粧料 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4976629B2 (ja) * | 2001-09-27 | 2012-07-18 | コンビ株式会社 | 美肌促進剤 |
CN102334680B (zh) * | 2011-08-08 | 2012-12-19 | 邓毛程 | 一种红曲燕窝及其制备方法 |
CN102362637B (zh) * | 2011-09-30 | 2013-03-13 | 邓毛程 | 利用微生物活菌悬液和/或粗酶液去除燕窝中亚硝酸盐的方法与应用 |
CN104146885A (zh) * | 2014-07-14 | 2014-11-19 | 武汉中科光谷绿色生物技术有限公司 | N-乙酰神经氨酸水合物在育发产品中的应用 |
-
2015
- 2015-06-25 SG SG11201705801VA patent/SG11201705801VA/en unknown
- 2015-06-25 WO PCT/JP2015/003205 patent/WO2016125208A1/ja active Application Filing
- 2015-06-25 JP JP2016572943A patent/JP6651466B2/ja active Active
- 2015-06-25 CN CN201580074756.3A patent/CN107405365B/zh active Active
Patent Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0242962A (ja) * | 1988-08-04 | 1990-02-13 | Susumu Murofushi | 機能性食品の製造方法 |
JPH05214003A (ja) * | 1992-02-04 | 1993-08-24 | Mect Corp | 好中球遊走阻止薬 |
JP2002068988A (ja) * | 2000-08-23 | 2002-03-08 | Combi Corp | ウイルス感染抑制剤及びそれを含有する飲食品 |
JP2003259835A (ja) * | 2001-12-28 | 2003-09-16 | Oubiken:Kk | 発酵製品の製造とその利用 |
JP2003292444A (ja) * | 2002-02-04 | 2003-10-15 | Kyowa Hakko Kogyo Co Ltd | インスリン分泌促進剤 |
JP2005185242A (ja) * | 2003-12-26 | 2005-07-14 | Takashi Kondo | プラセンタを含有した健康食品及びその製造方法 |
JP2005185241A (ja) * | 2003-12-26 | 2005-07-14 | Takashi Kondo | 発酵健康食品及びその製造方法 |
JP2007061058A (ja) * | 2005-09-02 | 2007-03-15 | Hideo Yamamoto | 糖鎖栄養素を含む免疫強化食品及びその製造方法 |
JP2008189635A (ja) * | 2007-02-08 | 2008-08-21 | Nippon Zoki Pharmaceut Co Ltd | 疼痛疾患治療剤 |
WO2009008362A1 (ja) * | 2007-07-12 | 2009-01-15 | Yotsuba Milk Products Co., Ltd. | シアル酸化合物含有組成物の製造方法 |
JP2014159491A (ja) * | 2014-06-09 | 2014-09-04 | Combi Corp | コラーゲン産生低下抑制剤、それを含む皮膚外用組成物および化粧料 |
Non-Patent Citations (1)
Title |
---|
今堀和友ほか監修, 生化学辞典(第3版), JPN6019040721, 1998, pages 520, ISSN: 0004138961 * |
Also Published As
Publication number | Publication date |
---|---|
CN107405365B (zh) | 2021-06-01 |
CN107405365A (zh) | 2017-11-28 |
WO2016125208A1 (ja) | 2016-08-11 |
SG11201705801VA (en) | 2017-08-30 |
JP6651466B2 (ja) | 2020-02-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2484340B1 (en) | Collagen production accelerating composition | |
RU2581916C2 (ru) | Композиция для стимулирования продуцирования ламинина-332 | |
EP2931289B1 (fr) | Chitine ou ses derives pour la prevention et/ou le traitement de parasitoses | |
JP6335508B2 (ja) | 成長ホルモン分泌促進剤 | |
US8962684B2 (en) | Antioxidant composition | |
WO2016125208A1 (ja) | アナツバメ巣を原材料とする素材、組成物及び素材の製造方法 | |
KR20180122380A (ko) | 피칼리박테리움속 세균증식제 | |
JP2009269832A (ja) | カルシトニン遺伝子関連ペプチド及びインスリン様成長因子−1の産生促進組成物 | |
US10925304B2 (en) | Method for treating chronic fatigue syndrome, idiopathic chronic fatigue, and fibromyalgia | |
JP2022115770A (ja) | 低温発酵減圧抽出法 | |
JP2020534281A (ja) | ベータグルカンを有効成分とする二日酔い解消用組成物またはアルコール性肝疾患の予防、改善または治療用組成物 | |
KR102581570B1 (ko) | 신규 바실러스 벨레젠시스 균주를 포함하는 면역증강용 조성물 | |
JP7104193B2 (ja) | 筋肉増強剤 | |
JP2004292355A (ja) | 抗ストレス剤 | |
JP2006075085A (ja) | パセリから得られる発酵物 | |
KR101184365B1 (ko) | 코디셉스 밀리타리스 kctc 11455 bp로 발효시킨 녹용을 유효성분으로 포함하는 항산화 및 성장촉진용 조성물 및 그 제조방법 | |
CN104523736B (zh) | 一种防治心肌梗死的药物组合物及其应用 | |
KR100829543B1 (ko) | 감마-아미노부틸산 함량이 증가된 유산균 발효물을포함하는 기억력 향상제 | |
KR20220115758A (ko) | 신규한 엔테로코커스 패칼리스 균주 및 락토코커스 락티스 균주, 및 이의 유청 발효물을 포함하는 구강질환 또는 대장질환의 예방 또는 개선용 식품 조성물 | |
KR101184359B1 (ko) | 바실러스 서브틸리스 kctc 11454 bp로 발효시킨 녹용을 유효성분으로 포함하는 항산화 및 성장촉진용 조성물 및 그 제조방법 | |
JP2020079309A (ja) | 筋肉増強剤 | |
CN117398415A (zh) | 嗜黏蛋白阿克曼菌以及相关组合物在制备血管钙化抑制剂中的应用 | |
JP2021038169A (ja) | 栄養素輸送促進剤 | |
HU190782B (en) | Process for producing pharmaceutical compositions for profilacting and treating negative changes of hygienics on epithelium | |
KR20080045320A (ko) | 감마-아미노부틸산 함량이 증가된 유산균 발효물과 그의제조방법 및 이를 포함하는 약제학적 제제 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20170710 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20180625 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20181203 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20190604 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20190730 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20190919 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20191023 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20191206 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20191224 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20200122 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6651466 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |